California Cancer Reporting System Standards, Volume III
California Hospital Transmit
Eureka Admission Level
Eureka Tumor Level
Fields:
Age at Diagnosis [NAACCR #230]
Primary Site [NAACCR #400]
Behavior Code ICD-O-3 [NAACCR #523]
Histologic Type ICD-O-3 [NAACCR #522]
Over-ride Age-Site-Morph [NAACCR #1990]
IF 313: Conflict among Age at Diagnosis [value], Primary Site [value], Histologic Type ICD-O-3 [value], Behavior Code ICD-O-3 [value], and Over-ride Age Site-Morph [value]
This edit is skipped if any of the following statements are true:
Age at Diagnosis is greater than 14.
Histologic Type ICD-O-3 is blank
Date of Diagnosis is < 2001.
This edit is based on the International Classification of Childhood Cancer (ICCC) CHILD-CHECK program edit of "Unlikely Combinations of Age and Tumour Type" as specified on page 11 of IARC Technical Report No. 29. It also includes SEER edits for ages 000 - 014 that were formerly part of the edit Age, Primary Site, Morphology ICDO3 (SEER IF15).
If the Over-ride Age/Site/Morph contains a '1' or '3' no further checking is done.
Note: Codes '2' and '3' have been added to the list of Over-ride Age/Site/Morph codes in the NAACCR v11.3 metafile. The code definitions are:
1 = Reviewed: An unusual occurrence of a particular age/site/histology combination for a given age group has been reviewed
2 = Reviewed: Case was diagnosed in utero.
3 = Reviewed: Conditions 1 and 2 above both apply
Blank = Not reviewed or reviewed and corrected
For each specified group in the following list, the Age/Primary Site/Morphology combinations require review.
Unlikely Combinations of Age and Tumor Type
ICCC Diagnostic Group: IIa Hodgkin Lymphoma
Histologic Type ICD-O-3: 9650-9667
Site: Any
Age at Diagnosis: 000 - 002
ICCC Diagnostic Group: IVa Neuroblastoma and Ganglioneuroblastoma
Histologic Type ICD-O-3: 9490, 9500
Site: Any
Age at Diagnosis: 010 - 014
ICCC Diagnostic Group: V Retinoblastoma
Histologic Type ICD-O-3: 9510-9514
Site: Any
Age at Diagnosis: 006 - 014
ICCC Diagnostic Group: VIa Wilms tumor, rhabdoid, and clear cell sarcoma
Histologic Type ICD-O-3: 8960, 8964
Site: Any
Histologic Type ICD-O-3: 8963
Site: C649, C809
Age at Diagnosis: 009 - 014
ICCC Diagnostic Group: VIb Renal carcinoma
Histologic Type ICD-O-3: 8010-8041, 8050-8075, 8082,8120-8122,8130-8141, 8143, 8155, 8190-8201, 8210, 8211, 8221-8231, 8240,8241,8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8401, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8573
Site: C649
Histologic Type ICD-O-3: 8312
Site: Any
Age at Diagnosis: 000 - 008
ICCC Diagnostic Group: VIIa Hepatoblastoma
Histologic Type ICD-O-3: 8970
Site: Any
Age at Diagnosis: 006 - 014
ICCC Diagnostic Group: VIIb Hepatic carcinoma
Histologic Type ICD-O-3: 8010-8041, 8050-8075, 8082, 8120-8122, 8140,8141, 8143, 8155, 8190-8201, 8210, 8211, 8230, 8231, 8240, 8241, 8244-8246, 8260-8263, 8310, 8320, 8323, 8401, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8573
Site: C220, C221
Histologic Type ICD-O-3: 8160-8180
Site: Any
Age at Diagnosis: 000 - 008
ICCC Diagnostic Group: VIIIa Osteosarcoma
Hist_Type_3: 9180-9200
Site: Any
Age at Diagnosis: 000 - 005
ICCC Diagnostic Group: VIIIb Chondrosarcoma
Hist_Type_3: 9220-9230
Site: Any
Histologic Type ICD-O-3: 9231, 9240
Site: C400-C419
Age at Diagnosis: 000 - 005
ICCC Diagnostic Group: VIIIc Ewing sarcoma
Histologic Type ICD-O-3: 9260
Site: C400-C419, C809
Histologic Type ICD-O-3: 9363, 9364
Site: C400-C419
Age at Diagnosis: 000 - 003
ICCC Diagnostic Group: Xb Non-gonadal germ cell
Histologic Type ICD-O-3: 9060-9102
Site: C000-C559, C570-C619, C630-C699, C739-C750,
C754-C809
Age at Diagnosis: 008 - 014
ICCC Diagnostic Group: Xd Gonadal carcinoma
Histologic Type ICD-O-3: 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8143, 8155, 8190-8201, 8210, 8211, 8221-8241, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8573
Site: C569, C620-C629
Histologic Type ICD-O-3: 8380, 8381, 8441-8473
Site: Any
Age at Diagnosis: 000 - 004
ICCC Diagnostic Group: XIb Thyroid carcinoma
Histologic Type ICD-O-3: 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8155, 8190, 8200, 8201, 8211, 8230, 8231, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480, 8481, 8500-8573
Site: C739
Histologic Type ICD-O-3: 8330-8350
Site: Any
Age at Diagnosis: 000 - 005
ICCC Diagnostic Group: XIc Nasopharyngeal carcinoma
Histologic Type ICD-O-3: 8010-8041, 8050-8075, 8082, 8120-8122,8130-8141, 8155, 8190, 8200, 8201, 8211, 8230, 8231, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480, 8481,8504, 8510, 8550, 8560-8573
Site: C110-C119
Age at Diagnosis: 000 - 005
ICCC Diagnostic Group: XIe Skin carcinoma
Histologic Type ICD-O-3: 8010-8041, 8050-8075, 8082, 8090-8110, 8140,8143, 8147, 8190, 8200, 8240, 8246, 8247, 8260, 8310, 8320, 8323, 8390-8420, 8430, 8480, 8542, 8560, 8570-8573, 8940
Site: C440-C449
Age at Diagnosis: 000 - 004
ICCC Diagnostic Group: XIf NOS carcinoma
Histologic Type ICD-O-3: 8010-8082, 8120-8155, 8190-8263, 8290, 8310, 8314-8323, 8430-8440, 8480-8580, 8940, 8941,
Site: C000-C109, C129-C218, C239-C399, C480-C488, C500-C559, C570-C619, C630-C639, C659-C729, C750-C809
Age at Diagnosis: 000 - 004
ICCC Diagnostic Group: XIIa Mesothelial neoplasms (M905)
Histologic Type ICD-O-3: 9050-9053
Site: Any
Age at Diagnosis: 000 - 014
Additional SEER Groups:
Cervix Uteri
Histologic Type ICD-O-3: Any
Behavior Code ICD-O-3: 2
Site: C530-C539
Age at Diagnosis: 000 - 014
Placenta: choriocarcinoma
Histologic Type ICD-O-3: 9100
Site: C589
Age at Diagnosis: 000 - 014
Esophagus, Small Intestine, Rectosigmoid, Rectum, Anus, Anal Canal, Gallbladder, Other Biliary Tract, Pancreas, Pleura, Breast, Uterus, NOS, Corpus Uteri, Penis
Histologic Type ICD-O-3: Any
Site: C150-C159, C170-C179, C199, C209, C210-C218, C239,
C240-C249, C250-C259, C384, C500-C509, C559, C540-C549, C609
Age at Diagnosis: 000 - 014
Colon, Trachea, Lung and Bronchus
Histologic Type ICD-O-3: Any other than carcinoid (8240-8245)
Site: C180-C189, C339, C340-C349
Age at Diagnosis: 000 - 014
Cervix Uteri
Histologic Type ICD-O-3: Any with Behavior ICD-O-3 of 3
Site: C530-C539
Age at Diagnosis: 000 - 014
Prostate: adenocarcinoma
Histologic Type ICD-O-3: 8140
Site: C619
Age at Diagnosis: 000 - 014
Multiple Myeloma
Histologic Type ICD-O-3: 9732
Site: Any
Age at Diagnosis: 000 - 014
Chronic Myeloid Leukemia
Histologic Type ICD-O-3: 9863, 9875, 9876, 9945
Site: Any
Age at Diagnosis: 000 - 014
Chronic Lymphocytic Leukemia
Histologic Type ICD-O-3: 9823
Site: Any
Age at Diagnosis: 000 - 014
| 2/20/08 | This edit was rewritten (and renumbered to 313)to match the edit Age, Primary Site, Morphology ICDO3--Pediatric (NPCR) in NAACCR 11.2. The CCR edit logic includes all dx year cases. NAACCR 11.2 notes this difference "This edit and the edit Age, Primary Site, Morphology ICDO3--Adult (SEER), replace the edit Age, Primary Site, Morphology ICDO3 (SEER IF15) for cases diagnosed on or after 01/01/2001. There is no overlap in the two edits. "This edit (Age, Primary Site, Morphology ICDO3--Pediatric (NPCR)) is for ages 000 - 014 and the edit Age, Primary Site, Morphology ICDO3--Adult (SEER) is for ages 015 and older. The field Over-ride Age/Site/Morph is shared by both edits and contains a "1" when the case has been reviewed and accepted as is. |
| 2010 | Data Changes: CCR names (Site; Hist Behavior 3; Hist Type 3; OR Age Site) changed to match NAACCR names. Added over-ride flag logic for 2 and 3. Updated the Specification section with logic that would skip the edit. |